100 related articles for article (PubMed ID: 12581880)
1. Sequences required for the transition from monomeric to homodimeric forms of thyroid hormone receptor alpha and v-erbA.
Zubkova I; Subauste JS
Mol Cell Endocrinol; 2003 Jan; 199(1-2):61-72. PubMed ID: 12581880
[TBL] [Abstract][Full Text] [Related]
2. Dimerization of v-erbA on inverted repeats.
Zubkova I; Subauste JS
Biochem Biophys Res Commun; 2002 May; 294(1):35-41. PubMed ID: 12054736
[TBL] [Abstract][Full Text] [Related]
3. V-erba homodimers mediate the potent dominant negative activity of v-erba on everted repeats.
Zubkova I; Subauste JS
Mol Biol Rep; 2004 Jun; 31(2):131-7. PubMed ID: 15293789
[TBL] [Abstract][Full Text] [Related]
4. Identification of DNA binding sites for the V-erbA oncoprotein, the viral homolog to thyroid hormone receptor alpha.
Harbers M; Wahlström GM; Vennström B
J Steroid Biochem Mol Biol; 1998 Nov; 67(3):181-91. PubMed ID: 9879977
[TBL] [Abstract][Full Text] [Related]
5. Dimerization interfaces of v-erbA homodimers and heterodimers with retinoid X receptor alpha.
Shen Q; Subauste JS
J Biol Chem; 2000 Dec; 275(52):41018-27. PubMed ID: 11018031
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the DNA-binding and dominant negative activity of v-erbA homodimers.
Subauste JS; Koenig RJ
Mol Endocrinol; 1998 Sep; 12(9):1380-92. PubMed ID: 9731706
[TBL] [Abstract][Full Text] [Related]
7. Requirements for repression of retinoid X receptor by the oncoprotein P75gag-v-erbA and the thyroid hormone receptors.
Wahlström GM; Vennström B
Mol Endocrinol; 1998 May; 12(5):645-53. PubMed ID: 9605927
[TBL] [Abstract][Full Text] [Related]
8. The oncoprotein P75gag-v-erbA represses thyroid hormone induced transcription only via response elements containing palindromic half-sites.
Wahlström GM; Harbers M; Vennström B
Oncogene; 1996 Aug; 13(4):843-52. PubMed ID: 8761306
[TBL] [Abstract][Full Text] [Related]
9. Cancer promoted by the oncoprotein v-ErbA may be due to subcellular mislocalization of nuclear receptors.
Bonamy GM; Guiochon-Mantel A; Allison LA
Mol Endocrinol; 2005 May; 19(5):1213-30. PubMed ID: 15650025
[TBL] [Abstract][Full Text] [Related]
10. V-erbA requires auxiliary proteins for dominant negative activity.
Hermann T; Hoffmann B; Piedrafita FJ; Zhang XK; Pfahl M
Oncogene; 1993 Jan; 8(1):55-65. PubMed ID: 8093812
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional repression by thyroid hormone receptors. A role for receptor homodimers in the recruitment of SMRT corepressor.
Yoh SM; Privalsky ML
J Biol Chem; 2001 May; 276(20):16857-67. PubMed ID: 11278601
[TBL] [Abstract][Full Text] [Related]
12. Modulation of thyroid hormone action by mutant thyroid hormone receptors, c-erbA alpha 2 and peroxisome proliferator-activated receptor: evidence for different mechanisms of inhibition.
Meier-Heusler SC; Zhu X; Juge-Aubry C; Pernin A; Burger AG; Cheng SY; Meier CA
Mol Cell Endocrinol; 1995 Jan; 107(1):55-66. PubMed ID: 7796935
[TBL] [Abstract][Full Text] [Related]
13. Divergent dimerization properties of mutant beta 1 thyroid hormone receptors are associated with different dominant negative activities.
Hao E; Menke JB; Smith AM; Jones C; Geffner ME; Hershman JM; Wuerth JP; Samuels HH; Ways DK; Usala SJ
Mol Endocrinol; 1994 Jul; 8(7):841-51. PubMed ID: 7984146
[TBL] [Abstract][Full Text] [Related]
14. Two silencing sub-domains of v-erbA synergize with each other, but not with RXR.
Martin B; Renkawitz R; Muller M
Nucleic Acids Res; 1994 Nov; 22(23):4898-905. PubMed ID: 7800478
[TBL] [Abstract][Full Text] [Related]
15. Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha.
Damm K; Evans RM
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10668-72. PubMed ID: 7902566
[TBL] [Abstract][Full Text] [Related]
16. Unliganded T3R, but not its oncogenic variant, v-erbA, suppresses RAR-dependent transactivation by titrating out RXR.
Barettino D; Bugge TH; Bartunek P; Vivanco Ruiz MD; Sonntag-Buck V; Beug H; Zenke M; Stunnenberg HG
EMBO J; 1993 Apr; 12(4):1343-54. PubMed ID: 8096810
[TBL] [Abstract][Full Text] [Related]
17. At least three subdomains of v-erbA are involved in its silencing function.
Busch K; Martin B; Baniahmad A; Renkawitz R; Muller M
Mol Endocrinol; 1997 Mar; 11(3):379-89. PubMed ID: 9058383
[TBL] [Abstract][Full Text] [Related]
18. The function of retinoid X receptors on negative thyroid hormone response elements.
Takeda T; Nagasawa T; Miyamoto T; Hashizume K; DeGroot LJ
Mol Cell Endocrinol; 1997 Apr; 128(1-2):85-96. PubMed ID: 9140079
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
[TBL] [Abstract][Full Text] [Related]
20. A choice between transcriptional enhancement and repression by the v-erbA oncoprotein governed by one nucleotide in a thyroid hormone responsive half site.
Andersson ML; Vennström B
Oncogene; 2000 Jul; 19(32):3563-9. PubMed ID: 10951561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
